The predictive value of schema modes on cognitive behavioral therapy outcome for patients with anxiety disorders
Recruiting
- Conditions
- Anxiety disorder: either an obsessive compulsive disorder, panic disorder and/or agoraphobia, social anxiety disorder or generalized anxiety disorder
- Registration Number
- NL-OMON21441
- Lead Sponsor
- Pro Persona
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 98
Inclusion Criteria
Adults between 18 and 65 years of age
- A primary diagnosis of obsessive compulsive disorder, panic disorder and/or agoraphobia, social anxiety disorder or generalized anxiety disorder, assessed with the Mini International Neuropsychiatric Interview (MINI; Overbeek, Schruers, & Griez, 1997, 1999).
- The patient is enrolled for CBT at Pro Persona anxiety department (Nijmegen, Arnhem, Ede or Tiel)
Exclusion Criteria
- A psychological treatment primarily focused on personality characteristics
- Mental disorders that need acute treatment and/or harm the validity of the measurements: a current psychotic episode, substance abuse or mental retardation
- An inability to speak and understand Dutch fluently
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The severity of patients'symtoms and general psychological functioning will be measured by the Outcome Questionnaire-45 (OQ-45; Lambert et al., 1996).
- Secondary Outcome Measures
Name Time Method The severity of disorder specific symptoms. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS; Goodman et al., 1989a) will be used as a clinician rated instrument in the OCD subgroup. Panic disorder with or without agoraphobia symptoms severity will be assessed with the Panic Disorder Severity Scale (PDSS; Shear et al., 1997; de Beurs, 2002). The Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 1987; van Vliet, 1999) will be administered to measure social anxiety symptoms severity in the SAD subgroup. Severity of generalized anxiety disorder symptoms will be measured for the GAD subgroup by the Penn State Worry Questionnaire (PSWQ; Meyer, Miller, Metzger, & Borkovec, 1990).